Global Neurology Devices Market to Reach US$ 25.1 Billion by 2032, Stimulated by the Growing Prevalence of Neurological Disorders

According to the latest report by IMARC Group, titled “Neurology Devices Market Report by Product (Neurostimulation Devices, Neurosurgery Devices, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices, and Others), End User (Hospitals, Ambulatory Surgery Centers, Neurology Clinics), and Region 2024-2032,” the global neurology devices market size reached US$ 13.4 Billion in 2023. Neurology devices are advanced medical equipment used to diagnose, treat, and prevent various neurological disorders and conditions. These devices encompass a wide range of tools and instruments, including neurostimulation devices, neurosurgical devices, neurointerventional devices, and devices for neuromonitoring. They have been pivotal in transforming neurocare, enabling non-invasive or minimally invasive interventions for conditions such as epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurological ailments. They work by assessing neural activities, stimulating neural responses, or facilitating surgical procedures to correct or alleviate the complications arising from these conditions. In recent years, these devices have become indispensable to neurological treatment protocols, ensuring accurate diagnosis and effective treatment outcomes.

Global Neurology Devices Market Trends:

The global neurology devices market is experiencing significant growth, primarily driven by factors such as an aging population, the increasing prevalence of neurological disorders, technological advancements, and heightened awareness about neurological diseases. Along with this, the rising geriatric population is a key demographic that is susceptible to neurological conditions, contributing to an escalated demand for neurology devices. Additionally, the escalating incidence of neurological disorders across the globe is propelling the need for advanced diagnostic and therapeutic equipment. In addition, the advent of novel technologies, such as AI-powered devices, neuro-robotics, and advanced imaging modalities, has revolutionized neurological care, paving the way for precise diagnosis and targeted treatments. Apart from this, increased healthcare spending and improved healthcare infrastructure, especially in emerging economies, are also positively influencing the market. Furthermore, the shift towards minimally invasive neurosurgeries is a significant trend driving the demand for specialized neurology devices. Another promising trend is the development and adoption of wearable neurology devices that enable continuous patient monitoring and remote neurological care. This, combined with the ongoing research and development activities to introduce more effective and efficient neurology devices, creates a positive market outlook. Looking forward, the market value is projected to reach US$ 25.1 Billion by 2032, expanding at a CAGR of 7.1% during 2024-2032.

Market Summary:

• Based on the product, the market has been segmented into neurostimulation, neurosurgery, interventional neurology, cerebrospinal fluid management, and other devices.
• On the basis of the end user, the market is segregated into hospitals, ambulatory surgery centers, and neurology clinics.
• Region-wise, the market has been segmented into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
• The competitive landscape of the market has also been examined, with some of the key players being Abbott Laboratories, B. Braun, Boston Scientific Corporation, Integra LifeSciences, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Penumbra Inc. and Stryker Corporation.

Report Scope:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800